FLT3 and acute myeloid leukemia: Among the differentially spliced transcripts in AML, FLT3, a receptor tyrosine-kinase known to be frequently mutated in AML, displays frequent exon skipping between exons 6 and 8 leading to more potent activation of STAT5 and ERK [98].